Decision-makers comparing On-Kare against incumbent or point solutions
Why On-Kare is built this way
A short list of decisions the product does not compromise on, and the reasoning behind each.
Decisions we don't compromise on
One record, not synchronised copies
Pro, Me and One read and write the same record. The trade-off: every new capability must fit that record's shape rather than bring its own database.
A human signs anything clinical
Explained in full on the intelligence pages. The trade-off: some workflows are slower than a fully automated alternative would be.
Data leaves on request
A customer's record can be exported in a documented format. The trade-off: we compete on the product every renewal, not on switching cost.
The six questions
- What is it?
- The reasoning behind the product's structural choices, stated as decisions rather than as marketing claims.
- Who is it for?
- Decision-makers weighing On-Kare against an incumbent system or a set of point tools.
- Which problem does it solve?
- Most platform pitches describe features; they rarely explain what the vendor refused to do and why.
- How does it work?
- One record instead of synchronised copies, because synchronisation is where clinical data drifts. Human sign-off on anything clinical, because a model's confidence is not accountability. Exportable data, because a record that cannot leave is a record held hostage.
- How is it different?
- Each decision here has a trade-off named next to it, instead of being presented as a pure advantage.
- What is the proof?
- The platform and intelligence pages show these decisions in the actual architecture, not just in this statement.
This page is part of a platform of 2,156 clinical and operational capabilities across 8 business domains.
Explore the catalogueContinue
A short list of decisions the product does not compromise on, and the reasoning behind each.